Global Diphtheria Market
Healthcare Services

The Future of theDimethyl Ether Market: Growth Trends, Market Size, and Opportunities to Watch

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theDiphtheria Market?

The increase in bacterial infections is anticipated to fuel the diphtheria market’s expansion. Bacterial infections refer to diseases or conditions that arise due to bacterial growth or the toxins they produce, which infiltrate the body. Diphtheria is a severe disease resulting from strains of bacteria that compromise the immune system and foster the growth of Corynebacterium diphtheria. For instance, the UK-based government website GOV.UK reported in September 2024 that during the financial year 2022 to 2023, England’s NHS acute trusts reported 38,757 cases of E. coli bacteremia, with 7,881 instances (20.3%) being identified as hospital-onset infections. Hence, the increasing occurrence of bacterial infections is expected to stimulate the diphtheria market.

Diphtheria Market Driver: Growing Immunization Programs Fuelling The Diphtheria Market

 

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

How Has the Diphtheria Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The market size for diphtheria has seen substantial growth lately. It is projected to escalate from $8.91 billion in 2024 to $9.51 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.7%. The growth during the historical period is due to factors such as the development of vaccines, immunization drives, enhanced awareness, and improvement in healthcare infrastructure.

The diphtheria market is projected to experience significant expansion in the coming years. The market is forecasted to increase to $12.35 billion in 2029, achieving a compound annual growth rate (CAGR) of 6.8%. The expected growth within the forecast period can be ascribed to factors such as rising outbreaks, the implementation of booster vaccination programs, international travel and migration, and public health readiness. Key trends within this forecast span involve combination vaccines, the use of telemedicine for vaccinations, initiatives for vaccine equity, and public-private collaborations.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13016

What Key Market Trends and Innovations Are Shaping the Future of theDiphtheria Industry?

Leading firms in the diphtheria market are advancing their standing by developing innovative medicines and securing approval for their use. For instance, in October 2022, UK-based pharmaceutical and biotech company GlaxoSmithKline PLC disclosed that the U.S. Food and Drug Administration (FDA) had greenlighted BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap). This immunization is intended for use during the third trimester of pregnancy to protect against pertussis (also known as whooping cough) in babies under two months old. Administering the Tdap vaccine during gestation provides the most effective whooping cough protection for newborns in their early months. When pregnant women receive this immunization, they pass on protective antibodies to their children.

Which Companies Are Leading the Charge in Expanding theDiphtheria Market Growth?

Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

How is the Global Diphtheria Market Segemented?

The diphtheria market covered in this report is segmented –

1) By Type: Diphtheria, Skin Diphtheria, Other Types

2) By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis

3) By Treatment: Antibiotics, Antitoxin, Other Treatments

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Diphtheria: Respiratory Diphtheria, Non-respiratory Diphtheria

2) By Skin Diphtheria: Cutaneous Diphtheria

3) By Other Types: Diphtheritic Myocarditis, Diphtheritic Neuritis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13016&type=smp

Which Geographics are Influencing the Growth of the Diphtheria Market?

Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Diphtheria Market 2025, By The Business Research Company:

E-Pharmacy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Generic Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: